PDL BioPharma to Present at the Jefferies 2012 Global Healthcare Conference
INCLINE VILLAGE, Nev., June 4, 2012 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin, the company's president and chief executive officer, is scheduled to present at the Jefferies 2012 Global Healthcare Conference on Wednesday, June 6, 2012, at 4:00 p.m. ET in New York City.
This presentation will be available to interested parties through a live and archived audio webcast. To access the live and subsequently archived webcasts of the presentation, go to the Company's website at http://www.pdl.com and go to "Company Presentations & Events." Please connect to the website at least 15 minutes prior to the event to allow for any software download that may be necessary. The archived webcast will be available for seven days following the presentation.
About PDL BioPharma
PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. Today, PDL is focused on intellectual property asset management, investing in new revenue generating assets and maximizing the value of its patent portfolio and related assets. For more information, please visit www.pdl.com.
NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.
SOURCE PDL BioPharma, Inc.
More by this Source
PDL BioPharma Completes Regular Quarterly Dividend Payment
Jun 12, 2013, 16:02 ET
PDL BioPharma Provides Second Quarter 2013 Royalty Revenue Guidance of $143 Million
Jun 11, 2013, 16:02 ET
PDL Files for Arbitration Against Genentech Based on Underpayment of Royalties
Jun 11, 2013, 07:00 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.